{"DataElement":{"publicId":"2688567","version":"1.1","preferredName":"Stage Prognostic Factor Collaborative Staging Neoplasm Size Code","preferredDefinition":"Records the largest dimension or diameter of the primary tumor in millimeters.","longName":"2688565v1.0:2647228v1.0","context":"PS-CC","contextVersion":"1","DataElementConcept":{"publicId":"2688565","version":"1","preferredName":"Stage Prognostic Factor Collaborative Staging Neoplasm Size","preferredDefinition":"Used to record the largest dimension, or the diameter of the primary tumor in millimeters (for example:  1 mm = 001, 1 cm = 010).","longName":"2688190v1.0:2688563v1.0","context":"PS-CC","contextVersion":"1","ObjectClass":{"publicId":"2688190","version":"1","preferredName":"Stage Prognostic Factor","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.:The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome.","longName":"C16899:C18959","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prognostic Factor","conceptCode":"C18959","definition":"The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C0FC8A1-D62E-5124-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-10-09","modifiedBy":"ONEDATA","dateModified":"2007-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2688563","version":"1","preferredName":"Collaborative Staging Neoplasm Size","preferredDefinition":"A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits).:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.:Size; the physical magnitude of something.","longName":"C62575:C3262:C25681","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Collaborative Staging","conceptCode":"C62575","definition":"A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Size","conceptCode":"C25681","definition":"The physical magnitude of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C297AF5-27D0-74FB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-10","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-10-10","modifiedBy":"ONEDATA","dateModified":"2007-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C297AF5-27E1-74FB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-10","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-10-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2647228","version":"1","preferredName":"Collaborative Staging Neoplasm Size Code","preferredDefinition":"A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits)._(TOO-mer) An abnormal mass of tissue that results from excessive cell division. Tumors perform no useful body function. They may be benign (not cancerous) or malignant (cancerous)._Size; the physical magnitude of something._A system of numbered categories for representation of data. [Explanatory Comment: See the Collabortive Staging Manual and Coding instructions, Version 1.0 for site-specific codes and coding rules.]","longName":"2647228v1.0","context":"PS-CC","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2647227","version":"1","preferredName":"Collaborative Staging Neoplasm Size Code","preferredDefinition":"A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits).:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.:Size; the physical magnitude of something.:A system of numbered categories for representation of data.","longName":"C62575:C3262:C25681:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Collaborative Staging","conceptCode":"C62575","definition":"A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Size","conceptCode":"C25681","definition":"The physical magnitude of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"322DEF66-F80B-1316-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-05","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-05","modifiedBy":"ONEDATA","dateModified":"2007-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"322DEF66-F81C-1316-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-05","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-05","modifiedBy":"CURTIST","dateModified":"2009-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2193114","version":"1","longName":"Division of Cancer Control and Population Sciences","context":"PS-CC","ClassificationSchemeItems":[{"publicId":"3134707","version":"1","longName":"NAACCR 12.1","context":"PS-CC"},{"publicId":"5899833","version":"1","longName":"NAACCR 16","context":"PS-CC"},{"publicId":"5899845","version":"1","longName":"StageProgFactors16","context":"PS-CC"},{"publicId":"7464305","version":"1","longName":"NAACCR 18","context":"PS-CC"},{"publicId":"7464319","version":"1","longName":"StageProgFactors18","context":"PS-CC"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"STG_TUM_SIZE_CD","type":"C3D Name","context":"NCIP"},{"name":"2800","type":"NAACCR Item #","context":"PS-CC"},{"name":"CS TUMOR SIZE","type":"NAACCR Item Name","context":"PS-CC"},{"name":"CS Tumor Size","type":"NAACCR Item Name","context":"PS-CC"}],"ReferenceDocuments":[{"name":"Collaborative Staging Tumor S","type":"Preferred Question Text","description":"Collaborative Staging Tumor Size","url":null,"context":"PS-CC"},{"name":"Collaborative Staging (CS) Reference Manuals","type":"REFERENCE","description":"The Collaborative Stage Data Collection System (CS) Web pages serve as the main repository for CS-related items including coding instructions, software, and education and training resources for cancer registrars and cancer registry software vendors.","url":"http://www.cancerstaging.org/cstage/manuals.html","context":"PS-CC"},{"name":"AJCC Cancer Staging Manual","type":"REFERENCE","description":"See the AJCC Cancer Staging Manual, current edition, for site-specific categories for the TNM elements and stage groups.","url":null,"context":"PS-CC"},{"name":"SEER Coding and Staging Manuals","type":"REFERENCE","description":"Coding and Staging Manuals for the Surivellance Epidemiology and End Results Program","url":"http://seer.cancer.gov/tools/codingmanuals/index.html","context":"PS-CC"},{"name":"Rationale","type":"COMMENT","description":"CS is a group of data items set up by a joint task force including representatives from SEER, ACoS, CDC, NAACCR, NCRA, and AJCC, designed to provide a single uniform set of codes and rules for coding EOD/stage information to meet the needs of all of the participating standard setters. CS incorporates all of the fields from SEER 10-digit EOD, in a modified form, and adds several additional fields. When CS data items are coded, a computer algorithm allows generation of AJCC Sixth Edition TNM stage, SEER Summary Stage 1977, and SEER Summary Stage 2000. Separate CS fields are provided in the NAACCR record for these outputs.","url":null,"context":"PS-CC"},{"name":"FORDS Manual, Revised 2009","type":"REFERENCE","description":"See FORDS Manual for specifications of codes and data entry rules.","url":"http://www.facs.org/cancer/coc/fords/2009/fords2009.pdf","context":"PS-CC"},{"name":"CS Tumor Size Description","type":"COMMENT","description":"This belongs to the set of Collaborative Staging (CS) data items effective with 2004 diagnosis. See the CS schemes for site-specific variants. For many sites, the CS algorithm uses this data item to derive the Derived AJCC T [2940] according to the sixth edition of AJCC Cancer Staging Manual.  Tumor size at diagnosis is an independent prognostic indicator for many tumors and it is used by Collaborative Staging to derive some TNM-T codes.","url":null,"context":"PS-CC"},{"name":"NAACCR 12.1, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&tabid=133&mid=473","context":"PS-CC"},{"name":"NAACCR 16, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)","url":"https://www.naaccr.org/data-standards-data-dictionary/","context":"PS-CC"}],"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD8995A7-E5F5-0794-E040-BB89AD434F5A","latestVersionIndicator":"Yes","beginDate":"2010-06-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-09-22","modifiedBy":"HARTLEYG","dateModified":"2018-11-06","changeDescription":"090/22/2011 - tc - Updated with new definition as per V12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}